NCT03634436View on ClinicalTrials.gov

The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions
Hypercholesteremia
Interventions
DRUG

SHR-1209

"Pharmaceutical form: lyophilized formulation~Route of administration: subcutaneous"

DRUG

Placebo

"Pharmaceutical form: lyophilized formulation~Route of administration: subcutaneous"

Trial Locations (1)

Unknown

FuWai Hospital , Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03634436 - The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects | Biotech Hunter | Biotech Hunter